🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the efficacy of a single intraven...
Status
Completed
Location
Duke University Medical Center
Start Date
2010-06
Trial ID
NCT01147653
Treatments Being Tested
This phase III ALCHEMIST trial studies how well erlotinib hydrochloride com...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-02-11
Trial ID
NCT02193282
This study is a 4-arm, multicenter, randomized, partly double- blind, contr...
Status
Completed
Location
Abteilung Infektiologie Klinik für Innere Medizin II Department Innere Medizin Universitätsklinikum Freiburg
Start Date
2021-01-08
Trial ID
NCT04681430
Treatments Being Tested
This is a Phase III randomised, double-blind, multi-centre study to evaluat...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-01-04
Trial ID
NCT03737643
Treatments Being Tested
A phase II, multicenter, randomized, double-blind, placebo-controlled study...
Status
Unknown
Location
Cancer hospital, Chinese academy of medical science
Start Date
2011-05
Trial ID
NCT01527864
Treatments Being Tested
This is a study to evaluate the safety and efficacy of EIK1001 administered...
Status
Recruiting
Location
Southern Cancer Center, P.C.
Start Date
2026-06-15
Trial ID
NCT07365319
Multicenter, double-blind, placebo-controlled, randomized trial. Patients ...
Status
Recruiting
Location
IRCCS Istituto delle Scienze Neurologiche di Bologna
Start Date
2025-11-12
Trial ID
NCT06964815
Treatments Being Tested
Prospective, multi-centre, randomized, double-blind trial to assess efficac...
Status
Terminated
Location
IRCCS Sacro Cuore Don Calabria hospital
Start Date
2020-07-31
Trial ID
NCT04438850
Treatments Being Tested
This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinet...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2016-11
Trial ID
NCT02960581
This will be a (2 visit) double-blind, randomized, placebo crossover design...
Status
Completed
Location
Applied Science and Performance Institute
Start Date
2024-07-12
Trial ID
NCT06505239
Treatments Being Tested